Ossiam Purchases 39,578 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Ossiam boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 52.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 115,662 shares of the pharmacy operator's stock after purchasing an additional 39,578 shares during the quarter. Ossiam's holdings in Walgreens Boots Alliance were worth $1,079,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in WBA. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at about $946,000. Dimensional Fund Advisors LP boosted its stake in Walgreens Boots Alliance by 17.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock valued at $17,016,000 after purchasing an additional 272,895 shares during the last quarter. First Trust Advisors LP purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at $368,000. Forum Financial Management LP increased its holdings in Walgreens Boots Alliance by 71.2% in the 4th quarter. Forum Financial Management LP now owns 19,725 shares of the pharmacy operator's stock worth $184,000 after buying an additional 8,206 shares in the last quarter. Finally, GeoWealth Management LLC lifted its stake in Walgreens Boots Alliance by 121.4% during the 4th quarter. GeoWealth Management LLC now owns 26,520 shares of the pharmacy operator's stock valued at $247,000 after acquiring an additional 14,541 shares during the period. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Down 0.2 %

NASDAQ WBA traded down $0.02 on Friday, reaching $11.01. 6,349,910 shares of the stock traded hands, compared to its average volume of 20,972,641. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a fifty day moving average price of $10.95 and a 200-day moving average price of $10.19. The company has a market cap of $9.52 billion, a price-to-earnings ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. During the same period in the prior year, the firm earned $1.20 earnings per share. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on WBA. Royal Bank of Canada increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 15th. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.